Allergen immunotherapy for the prevention of allergy: A systematic review and meta‐analysis
Year: 2016
Type: review
Study designs: Systematic Review, Meta-Analysis
Abstract: BACKGROUND: There is a need to establish the effectiveness, cost-effectiveness, and safety of allergen immunotherapy (AIT) for the prevention of allergic disease. METHODS: Two reviewers independently screened nine international biomedical databases. Studies were quantitatively synthesized using random-effects meta-analyses. RESULTS: A total of 32 studies satisfied the inclusion criteria. Overall, meta-analysis found no conclusive evidence that AIT reduced the risk of developing a first allergic disease over the short term (RR = 0.30; 95% CI: 0.04-2.09) and no randomized controlled evidence was found in relation to its longer-term effects for this outcome. There was, however, a reduction in the short-term risk of those with allergic rhinitis developing asthma (RR = 0.40; 95% CI: 0.30-0.54), with this finding being robust to a pre-specified sensitivity analysis. We found inconclusive evidence that this benefit was maintained over the longer term: RR = 0.62; 95% CI: 0.31-1.23. There was evidence that the risk of new sensitization was reduced over the short term, but this was not confirmed in the sensitivity analysis: RR = 0.72; 95% CI: 0.24-2.18. There was no clear evidence of any longer-term reduction in the risk of sensitization: RR = 0.47; 95% CI: 0.08-2.77. AIT appeared to have an acceptable side effect profile. CONCLUSIONS: AIT did not result in a statistically significant reduction in the risk of developing a first allergic disease. There was, however, evidence of a reduced short-term risk of developing asthma in those with allergic rhinitis, but it is unclear whether this benefit was maintained over the longer term. We are unable to comment on the cost-effectiveness of AIT.
Source: Pediatric Allergy and Immunology
DOI: 10.1111/pai.12661
Authors: Maria Kristiansen, Sangeeta Dhami, Gopal Netuveli, Susanne Halken, Antonella Muraro, Graham Roberts, Desiree Larenas‐Linnemann, Moises A. Calderón, Martin Penagos, George Du Toit, Ignacio J. Ansotegui, Jörg Kleine‐Tebbe, Susanne Lau, Paolo Maria Matricardi, Giovanni Pajno, Nikolaos G. Papadopoulos, Oliver Pfaar, Dermot Ryan, Alexandra F. Santos, Frans Timmermanns, Ulrich Wahn, Aziz Sheikh
Institutions: University of Copenhagen, University of East London, Odense University Hospital, University of Padua, University Hospital Southampton NHS Foundation Trust, NIHR Southampton Respiratory Biomedical Research Unit, St Mary's Hospital, David Hide Asthma and Allergy Research Centre, University of Southampton, Hospital Médica Sur, Royal Brompton Hospital, Imperial College London, St Thomas' Hospital, King's College London, Guy's and St Thomas' NHS Foundation Trust, IDCQ Hospitales y Sanidad, S.L.U., Charité – Universitätsmedizin Berlin, Stiftung Charité, University of Messina, National and Kapodistrian University of Athens, University of Manchester, Heidelberg University, Zentrum für Rhinologie und Allergologie, Medizinische Fakultät Mannheim, University of Edinburgh
Language: English
Subfield: Immunology and Allergy
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2521983393
